We can’t show the full text here under this license. Use the link below to read it at the source.
Thymol mitigates lipopolysaccharide-induced endometritis by regulating the TLR4- and ROS-mediated NF-κB signaling pathways
Thymol reduces inflammation in the uterus caused by bacterial toxins by controlling immune and stress-related signaling pathways
AI simplified
Abstract
Thymol markedly alleviated LPS-induced pathological injury and inflammation in mouse endometritis.
- Thymol reduced myeloperoxidase activity and the production of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in vivo.
- In vitro studies showed that thymol inhibited the expression of TNF-α, IL-1β, inducible nitric oxide synthase, and cyclooxygenase-2 in a dose-dependent manner.
- Thymol treatment inhibited the expression of the Toll-like receptor 4-mediated nuclear factor-κB pathway.
- Silencing of TLR4 blocked the activation of the NF-κB pathway.
- Thymol also reduced LPS-induced reactive oxygen species production in a dose-dependent manner.
AI simplified